We're usually told it's a big health and safety no-no to mix 'n' match medications, right? Well, here's an exception that affects diabetics. Apparently, youngsters with Type 1 diabetes and their parents/caregivers can safely mix rapid-acting and long-acting insulin analogs in the same syringe. The results of a new study published in the Journal of Pediatrics (April 2006) show that doing so does not compromise blood sugar stability in the long-term.
Examples of rapid-acting insulin analogues are Apridra and NovoRapid. Lantus is an examples of a long-acting insulin glargine. For some kids, mixing the two together could potentially reduce the number of insulin shots required daily. This is always good news for children and their parents.